Artwork

Content provided by Nick Zelt. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nick Zelt or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Are DOACs A Contra-indications | Late TNK for LVO Strokes

9:31
 
Share
 

Manage episode 433453789 series 3328037
Content provided by Nick Zelt. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nick Zelt or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The JournalFeed podcast for the week of August 5-9, 2024.

Monday Spoon Feed:

For acute ischemic stroke patients with recent DOAC ingestion who (1) had their DOAC level measured, (2) had DOAC reversal with idarucizumab, or (3) inadvertently received thrombolytics with DOAC subsequently discovered, there was not evidence of increased significant intracranial hemorrhage associated with off-label thrombolytic therapy.

Friday Spoon Feed:

In patients with large vessel occlusions(LVO) presenting 4.5-24 hours after onset, without access to endovascular thrombectomy (ET), tenecteplase(TNK) administration bested standard medical treatment(SMT) in 90-day disability-free recovery.

  continue reading

200 episodes

Artwork
iconShare
 
Manage episode 433453789 series 3328037
Content provided by Nick Zelt. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nick Zelt or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The JournalFeed podcast for the week of August 5-9, 2024.

Monday Spoon Feed:

For acute ischemic stroke patients with recent DOAC ingestion who (1) had their DOAC level measured, (2) had DOAC reversal with idarucizumab, or (3) inadvertently received thrombolytics with DOAC subsequently discovered, there was not evidence of increased significant intracranial hemorrhage associated with off-label thrombolytic therapy.

Friday Spoon Feed:

In patients with large vessel occlusions(LVO) presenting 4.5-24 hours after onset, without access to endovascular thrombectomy (ET), tenecteplase(TNK) administration bested standard medical treatment(SMT) in 90-day disability-free recovery.

  continue reading

200 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide